The Covid-19 pandemic completely changed life as we know it, altering social trends, changing consumer habits and nudging companies to disrupt or be disrupted. Being unable to adapt, many companies went under, with small and medium enterprises being most at risk. Looking beyond social and economic effects, the Covid-19 pandemic claimed the lives of hundreds of thousands, now edging closer towards 1 million, with people suffering from cancer, diabetes, heart disease or obesity bearing the highest health risks. Hence, we can only wonder how and when it will end.
The prospect of an effective vaccine is on everybody’s minds. While Russia announced the approval of the first COVID-19 vaccine for widespread use, the news was met with sharp criticism by experts, describing Russia’s approach as ‘reckless’ and ‘unethical’ - since phase 3 trials, essential for establishing vaccine risks and benefits, were omitted.
According to the Guardian, 139 vaccines are in pre-clinical trials, 25 are in phase 1, 15 in phase 2, and 7 in phase 3.
Under these circumstances, do you believe that a vaccine for Covid-19 will be approved before 2021?
What are your thoughts on Russia’s vaccine when it comes to health safety?
Should a Covid-19 vaccine be approved, do you expect the distribution to be symmetrical across the globe or not? Why?
Should the distribution of vaccines be asymmetrical, what economic and social measures could be taken to close the gap?